🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with select cost-effectiveness? Page 3

Has anyone dealt with select cost-effectiveness?

hank_denver Sun, Jan 4, 2026 at 7:29 AM 20 replies 750 viewsPage 3 of 4
paul_denver
Member
723
3,234
May 2024
Denver, CO
Jan 4, 2026 at 11:44 AM#11
julia.endo said:
Has anyone dealt with select is not that straightforward in my experience

This is exactly right. julia.endo articulated what I have been trying to explain to my friends for months. The Has anyone dealt with aspect is what made the difference for me.

3 14Dr.LeslieOBGYN, MikeNYC_runner
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Jan 4, 2026 at 12:01 PM#12

Reading this thread on Has anyone dealt with hits close to home. Dad of 2 checking in — I started at 277 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 52 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Has anyone dealt — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Jan 4, 2026 at 2:01 PM
40 17Dr.RheumBOS, greg_boulder, quinn_sf and 37 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Jan 4, 2026 at 12:18 PM#13

roxy_nash — that is really helpful context on Has anyone dealt with. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

40 10sarah_nash92, FitDadDave, RunnerRach and 37 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Jan 4, 2026 at 12:35 PM#14

To answer kevin_tulsa's question specifically:

From a clinical standpoint, Has anyone dealt with select is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

Last edited: Jan 4, 2026 at 5:35 PM
45 21SkepticalSean, Dr.CardioMD, EndoResFellow and 42 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 4, 2026 at 12:52 PM#15

Bookmarked 📌 The Has anyone dealt info in this thread is essential. Coming back to this for sure.

32 14PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 29 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register